Medtronic InSync Sentry’s EU debut
This article was originally published in The Gray Sheet
Executive Summary
Cardiac resynchronization therapy defibrillator device launches in Europe, following May 28 CE mark. The 40 cc InSync Sentry delivers 35 joules of energy and features OptiVol fluid-status monitoring to track accumulation in the lungs and thoracic cavity. FDA approval is expected by year-end...